- Home
- WHF vs ANIK Comparison
WHF vs ANIK Comparison
Compare WHF & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WHF | ANIK |
|---|---|---|
| Founded | 2011 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 162.2M | 142.5M |
| IPO Year | 2012 | 1993 |
Fundamental Metrics
Financial Performance| Metric | WHF | ANIK |
|---|---|---|
| Price | $7.02 | $9.48 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 2 | 1 |
| Target Price | $7.75 | ★ $16.00 |
| AVG Volume (30 Days) | ★ 235.7K | 168.7K |
| Earning Date | 11-10-2025 | 11-05-2025 |
| Dividend Yield | ★ 26.33% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.42 | N/A |
| Revenue | $76,339,000.00 | ★ $112,806,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.79 |
| P/E Ratio | $15.98 | ★ N/A |
| Revenue Growth | N/A | ★ 30.55 |
| 52 Week Low | $6.39 | $7.87 |
| 52 Week High | $11.31 | $18.37 |
Technical Indicators
Market Signals| Indicator | WHF | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 42.50 | 46.66 |
| Support Level | $6.76 | $9.37 |
| Resistance Level | $7.08 | $9.82 |
| Average True Range (ATR) | 0.20 | 0.20 |
| MACD | -0.08 | -0.01 |
| Stochastic Oscillator | 24.07 | 26.09 |
Price Performance
Historical ComparisonAbout WHF WhiteHorse Finance Inc.
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.